Req #: 1903104
Location: Seattle, Washington, United States
Job Category: Technical Development
Work Location: 400 Dexter Ave N. 98109
Organization: Supply Chain
Employee Status: Full-time
Job Type: Regular
Celgene is a worldwide biopharmaceutical company leading the way in medical innovation to help patients live longer and better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation and love of challenge. With a presence in more than 70 countries, and growing we are looking for talented people to grow our business, advance our science and contribute to our unique culture.
Manager, SC Process and Systems PTM-PTP
Bachelor’s Degree in Supply Chain, Information Systems, or Engineering.
5+ years of experience in Supply Chain or manufacturing environment within the bio-pharmaceutical industry for Cell Therapies.
The SC Process and systems manager will act as the primary contact to lead, develop and build a solid platform to support all required Oracle EBS related business processes under the Plan to Manufacture (PTM) and Procure to Pay (PTP) work stream, including all aspects of process orders for make-to-order and make-to-stock, inventory and warehouse management, manufacturing master data, oracle integration with manufacturing execution systems (MES), planned and unplanned procurement including inter-intra company inventory transfers. The SC Manager will work closely with cross functional teams to help develop the overall system design and data requirements and will identify, lead and implement supply chain system enhancements to accommodate new business requirements and enable process improvements.
Responsibilities will include, but are not limited to, the following:
Work cross functionally, including IT other work streams to support Cell Therapy supply chain process using Oracle EBS.
Support identifying and managing timelines, resources and tasks during all phases related with Supply Chain projects or initiatives, as well as ongoing business activities.
Support and lead continuous improvement opportunities for SC processes such as manufacturing order management for make-to-stock and make-to-order, inventory and warehouse management including physical inventory and cycle count, integration with product costing, planned and unplanned purchase requisitions
Lead solution designs of ERP related applications that impact demand and supply planning, with a primary focus on supporting Cell Therapy requirements.
Ensure proper reporting models are created for business operations
Write test plans, conduct quality assurance (QA) testing, support user acceptance tests (UAT)
Drive processes and systems transformation design to support future state (To-Be) processes aligned with Plan to Manufacture and Procure to Pay business requirements
Actively and periodically engage with business partners across master data, manufacturing and supply chain operations to analyze business requirements for supply chain, evaluate process improvements and propose feasible solutions-road maps
Develop project and training plans, assist IT with the implementation and project execution for the Forecast to Plan work stream
Bachelor’s Degree in Supply Chain, Information Systems, Business or Engineering.
5+ years of experience in supply chain or manufacturing environment (pharmaceutical industry preferred).
5+ years of experience using ERP systems (Oracle, SAP, JDE)
Ability to work independently and cooperatively in a diverse group
Ability to use tools and techniques for supporting the PTM and PTP work stream
Advance knowledge of personal computer applications such as Microsoft Office Suite
Ability to travel 10%
COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
'At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.'
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.